Table 1.

Metabolic comorbidities in the investigated patients.

Comorbidity	Number and Percentage of Total Patients (n=49)	Mean Age[years]	Percentage of Female Patients [%]
Peripheral insulin resistance	n= 18; 37%	63.9 ± 12.5	39
hypertension	n= 36; 74%	59.5 ± 16.5	25
obesity	n= 26; 53%	58.3 ± 15.6	42
hyperlipidemia	n= 21; 43%	59.7 ± 16.8	38
steatosis	n= 23; 47%	54.7 ± 15.6	30
atherosclerosis	n= 23; 47%	61.9 ± 14.8	39